Me
Medivation (Pfizer)
San Francisco CAFounded 2003500 employees
Private CapbiotechAcquiredOncology
Platform: Xtandi AR
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MED-3086 | MED-3086 | Preclinical | 2 | CFTR | AMLALS | ||
| Nidavorutinib | MED-1055 | Phase 2 | 1 | SMN2 | NASHMyelofibrosis | ||
| MED-3942 | MED-3942 | Phase 2 | 2 | Tau | NSCLC |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)